Oncogenes and Tumour Suppressor Genes Flashcards

1
Q

Define what a hallmark of cancer is

A

Characteristic that normal cells have to require to become tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major functional changes in cancer

A

Increased growth (regulation, environment )​

Failure to undergo apoptosis

Loss of differentiation

Failure to repair DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Oncogenes function

A

Components of GF signalling pathways = reg. cell proliferation + survival in response to GF stim

↳ mutated = ↑ product or altered products have ↑ activity = act in a dominant manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tumour suppressor gene function

A

Stop signal to uncontrolled growth, may inhibit cell cycle or trigger apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the effect of gain of function in oncogenes

A

an altered gene whose product can act ​
in a dominant fashion to help make a cell cancerous. ​

= leads to stimulated cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe how there is a loss of function in TSG and their its effect

A

2 inactivating mutations for TS functionally eliminate TSG = stim cell proliferation

=
a normal​ process to maintain control of cell division is lost

= enhances the​ likelihood that a cell can become cancerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain how tumour development in chickens led to the discovery of Rous Sarcoma Virus

A

The carcinogenic agent was small enough to pass through a filter​

Although the filter used excluded bacteria it was not small enough to exclude viruses​

Rous concluded that a virus must be responsible for the induction of tumour formation​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to induce sarcomas in other chickens

A

Chicken w/sarcoma in breast muscle
Remove sarcoma and break up into small chunks of tissue
Grind up sarcoma with sand
Collect filtrate that has passed through fine pore filter
Inject filtrate into young chicken
Observe sarcoma in injected chicken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the reaasons why retroviruses were important experimentally

A

Technological advances​
Funding ​
Improved tissue culture techniques​
The discovery of reverse transcriptase, RNA genome, replicates via ​DNA intermediate and that they are enveloped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe + explain discovery of the fundamental principle of oncogenes

A

Oncogenic transformation by RSV was found to be caused by an ​extra gene contained in its genome = ‘oncogene’ v-src​

Homologous sequences were found in uninfected chickens and other OG

​Fundamental principle: Oncogenes are alerted forms of normal genes or proto-oncogenes​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe oncogene hypothesis

A

V-src homologous seq in uninfected

So some genes of cancer causing viruses were mutated forms of the cellular gene not viral genes​

Conclusion = rous sarcoma viral gene was in fact a host gene that had ​been ‘kidnapped’ by the virus (and ‘transformed’ into an oncogene)​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe capture of c-src by retrovirus​

A

c-src (in host cell chromosomal DNA) included into viral sequences with the dsDNA provirus (from infection then reverse transcription)

Which is accidentally integrated next to c-src

Then packaged into capsid leading to RSV virion carrying src sequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe and explain the effect of integration of gene fragments in viruses

A

During evolution, virus can acquire gene fragments from host at integration sites = creation of oncogenes​

​Can phosphorylate cellular proteins and effect growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explained how Bishop/varmus showed that an oncogene was responsible for causing cancer

A

Identified v-src oncogene for causing cancer

Hybridization experiments = c-src gene was present in genome of many species

Showed that host cell c-src gene was normally involved in +ve regulation of cell growth and cell division

Following infection - v-src oncogene was expressed at high levels in host cell = uncontrolled cell division/growth and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain how cells can be transformed

A

​Various agents, including radiation, chemical carcinogens,

and

Exogenously added viruses, may transform cells by “switching on” the endogenous oncogenic information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do DNA viruses:
Encode
What can they cause

A

Encode various proteins along with ​environmental factors can initiate​ and maintain tumours


Can cause lytic infection = death of cellular host or can replicate own/hosts’ DNA and promote neoplastic transformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What do RNA viruses do

A

Integrate DNA copies of their genomes​ into HC genome and as​ these contain transforming oncogenes ​they induce cancerous transformation ​of the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Viral oncogenes transmission - how

A

Viral oncogenes can be transmitted by either DNA or RNA viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe what can lead to the activation of oncogenes

A

OG captured by animal retroviruses
+

altered in human cancer, activated by mutations, insertions, amplifications and translocations​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe oncogene activation

A

Translocation = DNA regulatory seq translocated from distant site alters expression of downstream gene

Mutation/deletion = protein w/altered structure/function

Duplication = ↑ synth. of encoded protein - activates by insertion nearby P-OG

  • ↑ synth. of encoded protein
    OR
  • Synthesis of a protein containing portions encoded by different genes. The fusion protein is no longer under normal control

Thus a protein-coding gene translocated from distant site fuses w/portion of gene causing formation of a fusion gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

4 types of proteins are involved in the transduction of growth signals​

A

Growth factors​
Growth factor receptors​
Intracellular signal transducers​
Nuclear transcription factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Explain the involvement of oncogenes with ras

A

Oncogenes act as GF, GFR and intracellular signalling molecules

Ras and Raf activate the ERK MAP kinase pathway,

leading to the induction of additional ​ genes (e.g. fos) that encode potentially oncogenic transcriptional regulatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ras proteins - definition

A

RAS proteins are small GTPases that are normally bound to GDP in a neutral state​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Ras mutations - effect

A

Loss of GTPase activity of the RAS protein ​

Hyperactive ras due to mutation so DNA damage repair is not allowed to happen ​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Ras activation - description

A
  1. Binding of EC GF signal ​

​2. Promotes recruitment of RAS proteins to the receptor complex ​

  1. Recruitment promotes Ras to exchange GDP (inactive ​Ras) with GTP (active Ras) ​

​4. Activated Ras then initiates the remainder of the ​signalling cascade (mitogen activated protein kinases)​

​5. These kinases ultimately phosphorylate targets, such as​ TF to promote expression of genes ​= growth + survival​

​Ras hydrolyzes GTP to GDP fairly quickly

26
Q

MYC onogenes - family description

A

C-MYC, MYCN, and MYCL, which encode c-Myc, N-Myc, ​

and L-Myc, respectively

27
Q

MYC oncogenes - regulate what

A

Belong to a family of TFs that regulate transcription of at least 15% of the entire genome

28
Q

MYC oncogenes - major downstream effectors

A

Include those involved in

RS biogenesis, translation, cell-cycle progression and metabolism,

orchestrating a broad range of biological functions,

such as cell proliferation, differentiation, survival, and immune surveillance ​

29
Q

MYC oncogenes - structure

A

Encodes a helix-loop-helix leucine zipper TF

that dimerizes with its partner protein, Max, to transactivate gene expression​

30
Q

MYC oncogenes - activation

A

Activated when under control of foreign transcriptional promoters (chromosomal translocation​)

=

deregulation of the oncogene

31
Q

Burkitt’s lymphoma - activation

A

BL = carry ⅓ CS translocation = MYC under reg of Ig heavy chain = CS 2/14/22 = a region from one of these is fused w/CS 8

32
Q

Chronic myelogenous leukaemia - mechanism

A

Carry the Philadelphia CS,​
that is the product of CST
t(9;22)(q34;q11) = BCR-ABL fusion protein​

= tyrosine kinase activity ​
of the oncogene ABL is constitutive leading to abnormal ​
proliferation

33
Q

Chronic myelogenous leukaemia - therapeutic strategies

A

Therapeutic strategies for CML include Imatinib (Gleevac) a tyrosine kinase inhibitor

34
Q

Identification of tumour suppressor genes - description

A

Somatic hybridization experiments

= fuse normal cells w/tumour cells

= cells produced can’t form tumours

= genes from normal inhibit/suppress tumour development

35
Q

Anti-oncogenes - description of how they arise

A

TSG products act as stop signs to uncontrolled growth, promote differentiation or trigger apoptosis​

Usually regulators of cell cycle checkpoints, differentiation or DNA repair

Loss of TSG function requires inactivation (mutation/deletion) of both alleles of the gene​

TSGs = recessive genes​

Sometimes referred to as ‘anti-oncogenes’

36
Q

Retinoblastoma - define

A

Retinoblastoma is a rare childhood cancer (1 in 20,000) that develops when ​immature retinoblasts continue to grow very fast and do not turn into ​mature retinal cells.

An eye that contains a tumour will reflect light back in a white colour.​

Often called a “cat’s eye appearance,” the technical term for this is leukocoria.

37
Q

Retinoblastoma - forms + difference between them

A

Two forms of the disease, familial (40%) and sporadic (60%)​

Heriditary tumour = 1 inherited and 1 acquired mutation thus 1 hit on somatic level

Sporadic tumour = 2 acquired mutations thus 2 hits on somatic level

38
Q

Retinoblastoma - cause

A

​The hereditary mutation is on chromosome 13 (13q14), ​

the retinoblastoma 1 (Rb1) gene

39
Q

Retinoblastoma - loss of heterozygosity description

A

“Loss of heterozygosity“ = inactivation of second TSG copy

heterozygous cell receives second hit in remaining copy of TSG = homozygous for mutated gene

40
Q

Retinoblastoma - family description

A

The Rb gene family includes three members: Rb/(p105/110), p107 and Rb2/p130​

-collectively known as pocket proteins​

41
Q

pRb - define

A

pRb is a multi functional protein (110kDa) with over 100 binding partners​

A transcriptional co factor that can bind to transcription factors

42
Q

Retinoblastoma - structure

A

structure = scaffold for multiple protein interactions ​

Large pocket = small pocket and C-terminus
N terminus at the end
Space w/in large pocket

It’s main binding partner is the E2F transcription factor, ​
interacting with the large pocket ​

43
Q

Retinoblastoma - interaction w/cell cycle

A

Main function of Rb is to regulate the cell cycle by inhibiting the G1 to S phase transition

44
Q

Cyclin D function in cell cycle

A

Cyclin D is first cyclin to be synthesized and drive progression through G1 together with cdks4/6​

​A key substrate for cyclin D is RB protein​

​Cyclin D and E families and their cdks phosphorylate RB

45
Q

Rb interaction w/E2F - description and effects

A

Rb protein regulates activity of E2F = crucial for expression of genes required for S phase​ ​

When Rb is dephosphorylated/hypophosphorylated it is active and remains bound to E2F​ ​

When Rb is active it blocks the progression of to S phase​

46
Q

E2F release and effect - description

A

Upon phosphorylation of RB, E2F is released and migrates to the nucleus to induce transcription ​

47
Q

Rb inactivation - list 3 ways

A

Phosphorylation
Mutation
Viral oncoprotein binding​

48
Q

Retinoblastoma - state of pRb

A

In retinoblastoma, pRb is functionally inactivated by mutations ​or partial deletions

49
Q

Viral inactivation in DNA viruses - cause

A

Viral inactivation found in small DNA tumour viruses​ mainly by disrupting E2F binding or destabilisation of Rb​

50
Q

RB phosphorylation in cancer cells and effect - description

A

Rb phosphorylation deregulated throughout cell cycle

= E2F TF can deregulate CC

= cells move from G1-S phase w/out checks

51
Q

p53 role and specialization

A

Sensing DNA damage and regulating cell death/apoptosis​ as well as other pathways

p53 specializes in preventing the appearance of abnormal cells

52
Q

Frequent mutation of p53 - effect

A

Frequent mutation of p53 in tumour cell genomes

suggests that tumour ​cells try to eliminate p53 function before they can thrive

53
Q

p53 - structure and binding capabilities

A

​Protein has an amino transactivation domain, a central DNA binding domain, a tetramerization domain and a carboxyl regulatory domain​

Can bind to around 300 different gene promoter regions-main role as a transcription factor

54
Q

Regulation of P53 by MDM2​ - description

A

p53 levels kept low by MDM2 (OG, ubiquitin ligase),

unstressed cells = p53/MDM2 move between nucleus/cytosol → MDM2 binds p53 = complex in nucleus,

MDM adds ubiquitin tag onto lysine residues at carboxyl terminus = targeted for degradation by proteasome

55
Q

Activation of p53 tumour suppressor​ and effect - description w/example

A

Stress signals are able to activate p53​

Signals are sensed by mainly kinases that then phosphorylate p53​

​Phosphorylation of p53 disrupts the interaction between it and ​MDM2​

​e.g. ionizing radiation signals through two kinases ATM/ATR​ activate oncogenes such as ras, induce activity of p14arf ​responsible for sequestering MDM2.​

​P53 can thus regulate genes involved in DNA damage repair, ​apoptosis and cell cycle arrest

56
Q

Why is p53 a promising therapeutic target

A

Role of p53 as star player in suppressing tumorigenesis makes it a promising therapeutic target

57
Q

Therapeutic strategies for p53

A

Correcting p53 mutation and restoring wild-type p53 function by targeting its regulators

58
Q

Describe use of PRIMA-1 in therapy

A

PRIMA-1, Restores mutant p53 by ​modifying the thiol groups in the core ​domain of the protein​

​Nutlin- is a potent MDM2 antagonist​

​RITA binds to p53 and can restore ​mutp53 activity​

59
Q

Inhibition of CRM1 - effect

A

​Inhibitors of CRM1 result in nuclear ​accumulation of p53

60
Q

4 uses of genetic analysis and personalised medicine

A

A detailed readout of the molecular faults in a patient’s tumour, and new generation of drugs that precisely target them ​

​Classifies tumours according to their genetic make-up instead of where they grow in the body​

​People with the ‘same’ cancer can have different forms of the disease so responses to treatment vary​

​Cancers growing in different parts of the body may also share the same genetic faults so respond to similar treatments